Education
About Us
Working with TipRanks
Follow Us
Actuate Therapeutics, Inc. (ACTU)
NASDAQ:ACTU
| Dec 24 | Dec 23 | Dec 22 | |
|---|---|---|---|
| Income Statement | |||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ 0.00 | $ 0.00 |
| Operating Income | $ -25.16M | $ -24.97M | $ -20.21M |
| EBITDA | $ -25.16M | $ -24.43M | $ -20.08M |
| Net Income | $ -27.29M | $ -24.74M | $ -20.16M |
| Balance Sheet | |||
| Cash & Short-Term Investments | $ 8.64M | $ 2.96M | $ 20.45M |
| Total Assets | $ 9.32M | $ 3.00M | $ 20.48M |
| Total Debt | $ 0.00 | $ 0.00 | $ 404.99K |
| Net Debt | $ -8.64M | $ -2.96M | $ -20.04M |
| Total Liabilities | $ 9.21M | $ 102.62M | $ 5.65M |
| Stockholders' Equity | $ 104.19K | $ -99.63M | $ 14.83M |
| Cash Flow | |||
| Free Cash Flow | $ -21.84M | $ -21.63M | $ -17.79M |
| Operating Cash Flow | $ -21.84M | $ -21.63M | $ -17.79M |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ 0.00 |
| Financing Cash Flow | $ 27.53M | $ 4.13M | $ 19.26M |
Actuate Therapeutics, Inc. Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.